Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, US Food and Drug Administration, 3900 NCTR Rd., AR, Jefferson, USA.
Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV, USA.
In Vitro Cell Dev Biol Anim. 2021 Feb;57(2):104-132. doi: 10.1007/s11626-020-00517-7. Epub 2020 Nov 11.
The lung is an organ that is directly exposed to the external environment. Given the large surface area and extensive ventilation of the lung, it is prone to exposure to airborne substances, such as pathogens, allergens, chemicals, and particulate matter. Highly elaborate and effective mechanisms have evolved to protect and maintain homeostasis in the lung. Despite these sophisticated defense mechanisms, the respiratory system remains highly susceptible to environmental challenges. Because of the impact of respiratory exposure on human health and disease, there has been considerable interest in developing reliable and predictive in vitro model systems for respiratory toxicology and basic research. Human air-liquid-interface (ALI) organotypic airway tissue models derived from primary tracheobronchial epithelial cells have in vivo-like structure and functions when they are fully differentiated. The presence of the air-facing surface allows conducting in vitro exposures that mimic human respiratory exposures. Exposures can be conducted using particulates, aerosols, gases, vapors generated from volatile and semi-volatile substances, and respiratory pathogens. Toxicity data have been generated using nanomaterials, cigarette smoke, e-cigarette vapors, environmental airborne chemicals, drugs given by inhalation, and respiratory viruses and bacteria. Although toxicity evaluations using human airway ALI models require further standardization and validation, this approach shows promise in supplementing or replacing in vivo animal models for conducting research on respiratory toxicants and pathogens.
肺是直接暴露于外部环境的器官。由于肺具有较大的表面积和广泛的通气,因此容易接触到空气中的物质,如病原体、过敏原、化学物质和颗粒物。为了保护和维持肺内的内环境稳定,人体已经进化出高度精细和有效的机制。尽管有这些复杂的防御机制,但呼吸系统仍然容易受到环境挑战的影响。由于呼吸暴露对人类健康和疾病的影响,人们一直非常关注开发用于呼吸毒理学和基础研究的可靠和可预测的体外模型系统。源自原代气管支气管上皮细胞的人液-气界面(ALI)器官型气道组织模型在完全分化时具有类似于体内的结构和功能。气-液界面的存在允许进行模拟人体呼吸暴露的体外暴露。可以使用颗粒物、气溶胶、气体、来自挥发性和半挥发性物质的蒸气以及呼吸道病原体进行暴露。已经使用纳米材料、香烟烟雾、电子烟蒸气、环境空气中的化学物质、吸入给药的药物以及呼吸道病毒和细菌来生成毒性数据。尽管使用人气道 ALI 模型进行毒性评估需要进一步的标准化和验证,但这种方法在补充或替代体内动物模型以进行呼吸毒物和病原体的研究方面显示出了潜力。